/PRNewswire/ The "Cell Therapies for Type I Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment".
NextCell Pharma AB have had their article detailing the results of their phase I/II clinical trial in type I diabetes accepted in the peer-reviewed journal Diabetologia.
NextCell Pharma AB is a. | March 28, 2023